VGLL4 抗体 (AA 136-163)
(2 references)Quick Overview for VGLL4 抗体 (AA 136-163) (ABIN1881992)
抗原
See all VGLL4 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 136-163
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This VGLL4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 136-163 amino acids from the Central region of human VGLL4.
-
亚型
- Ig Fraction
-
-
anti-Vestigial Like 4 (VGLL4) (AA 43-277) antibody
VGLL4 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Vestigial Like 4 (VGLL4) (AA 1-290) antibodyVGLL4 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-Vestigial Like 4 (VGLL4) (AA 96-296) antibodyVGLL4 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- WB: 1:1000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
有效期
- 6 months
-
-
-
: "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. ..." in: Gut, Vol. 58, Issue 8, pp. 1078-83, (2009) (PubMed).
: "Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes." in: The Journal of biological chemistry, Vol. 279, Issue 29, pp. 30800-6, (2004) (PubMed).
-
: "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. ..." in: Gut, Vol. 58, Issue 8, pp. 1078-83, (2009) (PubMed).
-
- VGLL4 (Vestigial Like 4 (VGLL4))
-
别名
- VGLL4
-
背景
- VGLL4 may act as a specific coactivator for the mammalian TEFs (By similarity).
-
分子量
- 30948
-
NCBI登录号
- NP_001121691, NP_001121692, NP_001121693, NP_055482
-
UniProt
- Q14135
抗原
-
